Adenovir Pharma AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.adenovir.com
Clinical Trials
4
Active:3
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
Phase 2
Completed
- Conditions
- Viral Conjunctivitis
- Interventions
- Drug: APD-209 Eye dropsDrug: APD-209 Placebo Eye drops
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Adenovir Pharma AB
- Target Recruit Count
- 47
- Registration Number
- NCT01977443
- Locations
- 🇩🇪
Augenklinik Universitätzmedizin Charité, Berlin, Germany
🇩🇪Universitätsklinikum Düsseldorf, Düsseldorf, Germany
🇩🇪Universitäts-Augenklinik Freiburg, Freiburg, Germany
News
No news found